Characterization of angiotensin II receptors in the rat fetus.
The presence of AII receptors during early and late embryonic development was studied by binding of 125I[Sar1, Ile8] AII to whole mouse blastocysts and membrane-rich fractions from rat conceptuses, 7 to 21 days in gestation. In early mouse embryos there was no detectable binding under a variety of experimental conditions. However, in late gestation rat fetuses, specific and high affinity binding was observed, with a concentration of sites similar in membranes from whole and eviscerated fetuses. Using less than 100 micrograms of membrane protein, binding was time and temperature dependent, maintaining equilibrium from 30 to 120 min at 23 degrees C and it was enhanced by addition of Mg+2 up to 5 mM, EGTA 2 mM and dithiothreitol up to 2.5 mM. Scatchard analysis of the binding data indicated Kd values ranging between 0.7 and 0.9 nM. Binding was first detectable at day 10 (14.3 +/- 2.3 fmol/mg), increasing to 104 +/- 16, 2,625 +/- 168, 5,993 +/- 152 and 5,902 +/- 92 by days 12, 15, 18, and 21 of gestational age, respectively. Since the functional significance of these binding sites depends on the availability of the agonist ligand, acid extracts from eviscerated 10-day-old fetuses were analyzed for the presence of AII. Measurement of AII by radioimmunoassay revealed immunoreactive AII-like material (845 pg/g of tissue), with an elution pattern identical to that of AII standard in a Sephadex G-50 column. This material was bioactive, as demonstrated by its ability to displace 125I[Sar1, Ile8]AII from adrenal glomerulosa membranes, an effect which was abolished by pretreatment of the extract with AII antibody.(ABSTRACT TRUNCATED AT 250 WORDS)
Section on Endocrine Physiology, National Institute of Child Health and Human Development, Bethesda, MD 20892.
C
C
Jones
M A
MA
Millan
F
F
Naftolin
G
G
Aguilera
D000804:Angiotensin II / Q000031:analogs & derivatives / Q000378:metabolism*; D000818:Animals; D001755:Blastocyst / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D005314:Embryonic and Fetal Development; D004791:Enzyme Inhibitors / Q000378:metabolism; D005260:Female; D005333:Fetus / Q000378:metabolism*; D007700:Kinetics; D011247:Pregnancy; D051381:Rats; D011945:Receptors, Angiotensin / Q000378:metabolism*
D004791:Enzyme Inhibitors; D011945:Receptors, Angiotensin; D000804:Angiotensin II; C032651:angiotensin II, Sar(1)-Ile(5)-